Search research articles
Contact Us
Filters
Showing results (61-70 of 298) with videos related to
Page
of 30
Sort By:
Journal of Parkinson'S Disease
|
February 20, 2025
Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease
David Bendetowicz, Vincent Planche, Erwan Bezard, et al.
NPJ Parkinson'S Disease
|
January 14, 2022
Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson's disease
Florent Laferrière, Stéphane Claverol, Erwan Bezard, et al.
Synapse (New York, N.Y.)
|
November 20, 2015
Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey
Mathieu Bourdenx, Sandra Dovero, Philippe De Deurwaerdère, et al.
Neurological Research
|
September 3, 2010
Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism
Pierre-Olivier Fernagut, Quentin Barraud, Erwan Bezard, et al.
Scientific Reports
|
April 5, 2017
Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model
Mathieu Bourdenx, Sandra Dovero, Marie-Laure Thiolat, et al.
British Journal of Pharmacology
|
October 25, 2019
Managing Parkinson's disease: moving ON with NOP
Daniela Mercatelli, Erwan Bezard, Roberto Eleopra, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 15, 2012
Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model
Jay S Schneider, Elsa Y Pioli, Yang Jianzhong, et al.
CNS & Neurological Disorders Drug Targets
|
March 31, 2023
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease
Erwan Bezard, David Gray, Rouba Kozak, et al.
Scientific Reports
|
August 10, 2017
Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease
Simone Bido, Federico N Soria, Rebecca Z Fan, et al.
Biological Psychiatry
|
July 13, 2007
Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway
Shuhong Guo, Jingqi Yan, Tangbin Yang, et al.
Page
of 30
Search research articles
Search
Showing results (61-70 of 298) with videos related to
Sort By:
Page
of 30
Journal of Parkinson'S Disease
|
February 20, 2025
Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease
David Bendetowicz, Vincent Planche, Erwan Bezard, et al.
NPJ Parkinson'S Disease
|
January 14, 2022
Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson's disease
Florent Laferrière, Stéphane Claverol, Erwan Bezard, et al.
Synapse (New York, N.Y.)
|
November 20, 2015
Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey
Mathieu Bourdenx, Sandra Dovero, Philippe De Deurwaerdère, et al.
Neurological Research
|
September 3, 2010
Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism
Pierre-Olivier Fernagut, Quentin Barraud, Erwan Bezard, et al.
Scientific Reports
|
April 5, 2017
Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model
Mathieu Bourdenx, Sandra Dovero, Marie-Laure Thiolat, et al.
British Journal of Pharmacology
|
October 25, 2019
Managing Parkinson's disease: moving ON with NOP
Daniela Mercatelli, Erwan Bezard, Roberto Eleopra, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 15, 2012
Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model
Jay S Schneider, Elsa Y Pioli, Yang Jianzhong, et al.
CNS & Neurological Disorders Drug Targets
|
March 31, 2023
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease
Erwan Bezard, David Gray, Rouba Kozak, et al.
Scientific Reports
|
August 10, 2017
Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease
Simone Bido, Federico N Soria, Rebecca Z Fan, et al.
Biological Psychiatry
|
July 13, 2007
Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway
Shuhong Guo, Jingqi Yan, Tangbin Yang, et al.
Page
of 30